Labcorp to speak at the Baird 2022 Global Healthcare Conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Sep. 6, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a fireside chat at the Baird 2022 Global Healthcare Conference on Tuesday, Sept. 13 , at 9:05 a.m. ET .

Labcorp acquires clinical outreach laboratory services from RWJBarnabas Health

BURLINGTON, N.C. --(BUSINESS WIRE)--Aug. 23, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has closed its acquisition of RWJBarnabas Health’s outreach laboratory business and select related assets. RWJBarnabas Health is New Jersey’s largest academic health system.

BD, Labcorp collaborate to develop flow cytometry-based companion diagnostics for matching patients with treatments

FRANKLIN LAKES, N.J., August 9, 2022 — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a collaboration agreement with Labcorp (NYSE: LH), a leading global life sciences company, creating a framework to develop, manufacture, market and commercialize flow cytometry-based companion diagnostics (CDx) intended to match patients with life-changing treatments for cancer and other diseases.

Labcorp announces 2022 second quarter results

Labcorp to spin off clinical development business

BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 28, 2022-- Labcorp (NYSE: LH) (the “Company”), a leading global life sciences company, today announced that its Board of Directors has authorized the Company to pursue a spin-off of the Company’s wholly owned Clinical Development business to Labcorp shareholders through a tax-free transaction.

Labcorp earns top score on 2022 Disability Equality Index

BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 22, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that it scored 100, the highest score possible, on the 2022 Disability Equality Index® (DEI), a comprehensive benchmarking tool for measuring disability inclusion in the workplace.

New Labcorp test report helps identify insect stings and improve therapy decisions to combat allergic reactions

BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 19, 2022-- Nearly 10 million people in the United States have a history of systemic or anaphylactic reaction to insect stings, with the risk of a severe and potentially life-threatening allergic reaction.

Labcorp expands automated clinical trial kit production line at European operations center

BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 18, 2022-- Labcorp ® (NYSE: LH), a leading global life sciences company, today announced an expansion of its automated clinical trial kit production line in Mechelen, Belgium.

Labcorp to announce second quarter financial results on July 28, 2022

BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 14, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, will release its financial results for the second quarter of 2022 before the market opens on Thursday, July 28, 2022 . The company will host a conference call and webcast beginning at 9 a.m. EDT that day to discuss the results.

Labcorp declares quarterly dividend

BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 14, 2022-- Labcorp (NYSE: LH) (the Company), a leading global life sciences company, announced today that its Board of Directors (the Board) has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on September 9, 2022 ,